Corey M. Beaubien traveled to the US Supreme Court in Washington DC in order to attend the oral arguments in Helsinn Healthcare v. Teva Pharmaceuticals. The arguments centered around whether the phrase “or otherwise available to the public” in Section 102 of the America Invents Act (AIA) expands or contracts the meaning of “on sale,” and particularly whether secret sales should qualify as on-sale prior art in the AIA era.
